Ken-ichiro Hamada
Suita, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1.
Journal: Cancers
Published: November 30, 2022
Complication rate, functional outcomes, and risk factors associated with carbon ion radiotherapy for patients with unresectable pelvic bone sarcoma.
Journal: Cancer
Published: March 02, 2020
Clinical Outcomes of Osteoarticular Extracorporeal Irradiated Autograft for Malignant Bone Tumor.
Journal: Sarcoma
Published: July 29, 2019
Silent subperiosteal iliac hematoma with bone radiolucency in adolescent male athletes.
Journal: Journal of orthopaedics
Published: July 25, 2019
Trabectedin is a promising antitumour agent for synovial sarcoma.
Journal: Journal of chemotherapy (Florence, Italy)
Published: April 15, 2016
Treatment outcomes of Japanese patients with Ewing sarcoma: differences between skeletal and extraskeletal Ewing sarcoma.
Journal: Japanese journal of clinical oncology
Published: October 26, 2015
Tailored therapeutic strategies for synovial sarcoma: receptor tyrosine kinase pathway analyses predict sensitivity to the mTOR inhibitor RAD001.
Journal: Cancer letters
Published: October 25, 2013
A novel angiomatoid epithelioid sarcoma cell line, Asra-EPS, forming tumors with large cysts containing hemorrhagic fluid in vivo.
Journal: BMC research notes
Published: April 23, 2013
SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: a study from the Japanese Musculoskeletal Oncology Group.
Journal: Cancer science
Published: April 25, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026